Detalhe da pesquisa
1.
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001.
Blood
; 143(5): 404-416, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37890149
2.
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.
Blood
; 143(17): 1713-1725, 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194692
3.
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma.
N Engl J Med
; 386(7): 629-639, 2022 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904798
4.
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.
Eur J Nucl Med Mol Imaging
; 50(11): 3349-3353, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37300573
5.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501490
6.
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study.
Lancet
; 396(10254): 839-852, 2020 09 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32888407
7.
Efficacy and safety of CD19-directed CAR-T cell therapies in patients with relapsed/refractory aggressive B-cell lymphomas: Observations from the JULIET, ZUMA-1, and TRANSCEND trials.
Am J Hematol
; 96(10): 1295-1312, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34310745
8.
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas.
Support Care Cancer
; 29(9): 5399-5408, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33694088
9.
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biol Blood Marrow Transplant
; 26(1): 189-196, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31493541
10.
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(6): 1218-1224, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30708189
11.
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.
Oncologist
; 24(7): 955-962, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568021
12.
Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Curr Oncol Rep
; 21(4): 35, 2019 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30848394
13.
Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy.
Blood
; 137(13): 1832-1835, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33156925
14.
A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma.
Br J Haematol
; 178(3): 434-441, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28440559
15.
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(6): 1030-1036, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26899561
16.
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(11): 1974-1982, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27544285
17.
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.
Blood
; 124(19): 2921-9, 2014 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25237196
18.
Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group.
Anticancer Drugs
; 27(1): 48-53, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26421462
19.
New meets old: a case study and review of novel therapeutics for the treatment of CLL in older patients.
J Natl Compr Canc Netw
; 12(10): 1371-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25313177
20.
CLL14 Trial: Fixed-Duration Chemotherapy-Free Regimen for Frail Patients with Treatment-Naïve CLL.
Oncology (Williston Park)
; 33(11)2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31769861